Transmedics Group Inc (NASDAQ: TMDX) is 7.38% higher on its value in year-to-date trading and has touched a low of $55.00 and a high of $177.37 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TMDX stock was last observed hovering at around $65.53 in the last trading session, with the day’s gains setting it 1.42%.
Currently trading at $66.95, the stock is 3.12% and -2.42% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.75 million and changing 2.17% at the moment leaves the stock -43.65% off its SMA200. TMDX registered -24.50% loss for a year compared to 6-month loss of -51.64%. The firm has a 50-day simple moving average (SMA 50) of $69.0354 and a 200-day simple moving average (SMA200) of $118.94185.
The stock witnessed a 9.72% gain in the last 1 month and extending the period to 3 months gives it a -46.97%, and is 7.03% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.11% over the week and 7.44% over the month.
Transmedics Group Inc (TMDX) has around 584 employees, a market worth around $2.25B and $401.09M in sales. Current P/E ratio is 71.73 and Fwd P/E is 45.57. Profit margin for the company is 8.14%. Distance from 52-week low is 21.73% and -62.25% from its 52-week high. The company has generated returns on investments over the last 12 months (4.50%).
with sales reaching $109.49M over the same period.The EPS is expected to grow by 227.30% this year, but quarterly earnings will post 77.76% year-over-year. Quarterly sales are estimated to grow 34.88% in year-over-year returns.
494.0 institutions hold shares in Transmedics Group Inc (TMDX), with institutional investors hold 115.32% of the company’s shares. The shares outstanding are 33.56M, and float is at 32.42M with Short Float at 27.73%. Institutions hold 111.61% of the Float.
The top institutional shareholder in the company is FMR LLC with over 4.49 million shares valued at $676.31 million. The investor’s holdings represent 13.7063 of the TMDX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 2.65 million shares valued at $398.47 million to account for 8.0755 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 2.53 million shares representing 7.7118 and valued at over $380.53 million, while DRIEHAUS CAPITAL MANAGEMENT LLC holds 4.5362 of the shares totaling 1.49 million with a market value of $223.83 million.
Transmedics Group Inc (TMDX) Insider Activity
The most recent transaction is an insider sale by Khayal Tamer I, the company’s Chief Commercial Officer. SEC filings show that Khayal Tamer I sold 1,083 shares of the company’s common stock on Jan 07 ’25 at a price of $80.05 per share for a total of $86694.0. Following the sale, the insider now owns 20843.0 shares.
Transmedics Group Inc disclosed in a document filed with the SEC on Dec 02 ’24 that Khayal Tamer I (Chief Commercial Officer) sold a total of 1,084 shares of the company’s common stock. The trade occurred on Dec 02 ’24 and was made at $86.40 per share for $93658.0. Following the transaction, the insider now directly holds 20843.0 shares of the TMDX stock.
Still, SEC filings show that on Nov 11 ’24, Khayal Tamer I (Chief Commercial Officer) disposed off 1,458 shares at an average price of $90.04 for $0.13 million. The insider now directly holds 20,843 shares of Transmedics Group Inc (TMDX).
